Infertility/ART/IVF

Thursday, November 30, 2017                                                                                                                                      Hall A

15:00-16:30 THE BEST RBMO PUBLICATIONS IN 2016-2017: THE EDITOR’S PICK
Chairperson Bart Fauser, The Netherlands
Women’s intentions to use fertility preservation to prevent age-related fertility decline
Anne ter Kerst, The Netherlands
microRNA miR-200b affects proliferation, invasiveness and stemness of endometriotic cells by targeting ZEB1, ZEB2 and KLF4
Martin Götte, Germany
16:30-18:00 UTERUS TRANSPLANTATION
Capsule Odyssey through the exciting development of recent years
Chairpersons Mats Brännström, Sweden
Rene Frydman, France
Victor Gomel, Canada
Surgical techniques of live donor uterus transplantation
Pernilla Dahm Kähler, Sweden
Results of surgery and the first post-transplantation year
Mats Brännström, Sweden
Obstetric pitfalls and results
Pernilla Dahm Kähler, Sweden
Bioengineered uterus: The future?
Mats Brännström, Sweden

Friday, December 1, 2017                                                                                                                                             Hall A

08:30-10:00 FERTILITY PRESERVATION
Capsule “Cancer patients should be informed of options for fertility preservation and future reproduction prior to cancer treatment” (ASRM). However, many oncologists and gynecologists are not fully aware of the current options and results
Chairpersons Dominique de Ziegler, France
Claus Yding Andersen, Denmark
Medical protection of gonadal damage
Marie-Madeleine Dolmans, Belgium
Ovarian tissue transplantation techniques and results
Jacques Donnez, Belgium
Ovarian tissue freezing and fertility preservation beyond cancer patients
Claus Yding Andersen, Denmark
Fertility preservation in BRCA mutation carriers: Ready for prime time?
Edgardo Somigliana, Italy
10:00-10:20 coffee break & poster viewing
10:20-11:50 INDUSTRY-SUPPORTED SYMPOSIUM
11:50-12:10 Break
12:10-13:40 INDUSTRY-SUPPORTED SYMPOSIUM
13:40-14:30 lunch break
14:30-16:30 IT’S ALL IN THE CHROMOSOMES?
Capsule We are waking to the fact that the early embryos have tremendous correction mechanisms that complicate the selection process. By germline editing, are we getting closer to the first step in creating the “homo deus”?
Chairpersons Rita Vassena, Spain
Georg Griesinger, Germany
The mismeasurement of mosaicism in human embryos
David Albertini, USA
Debate:
Proposition: Viable aneuploidy embryos should not be transferred
Jacques Cohen, USA
Opposition: Aneuploidy embryos can be transferred
Siobhan Quenby, UK
Discussion
Human germline gene editing: Are we ready?
Rita Vassena,
Spain
COGI-RBMO countercurrent lecture
Oocyte quality deterioration with age has little to do with chromosomes
David Albertini, USA
16:30-16:50 coffee break & poster viewing
16:50-18:20 IMPLANTATION FAILURE
Capsule Implantation failure is multi-factorial and common. Do we have new understandings and solutions?
Chairpersons Rene Frydman, France
David Albertini, USA
Endometrial cellular senescence and implantation failure
Jan Brosens, UK
Endometrial receptivity: How to assess it and is it key to embryo wastage?
Georg Griesinger, Germany
Diagnosis and treatment of endometrial receptivity
Xavier Santamaria, Spain

Saturday, December 2, 2017                                                                                                                                         Hall A

08:30-10:00 ASSISTED REPRODUCTION: FUTURE PERSPECTIVES
Capsule Individualization of stimulation, “freeze all” and social freezing are flowing into our discipline and, as usual, stirring considerable controversies
Chairpersons Bart Fauser, The Netherlands
Zion Ben Rafael,
Israel
Andrea Weghofer,
Austria
Debate: Individualized stimulation: The way to go or an unnecessary effort?
Pro: Dominique de Ziegler, France
Con: Frank Broekmans, The Netherlands
Discussion
The dilemma of social freezing: “Houston we have a problem”
Zion Ben Rafael, Israel
The “freeze all” concept in assisted reproduction: An option for everyone?
Andrea Weghofer, Austria
10:00-10:20 coffee break & poster viewing
10:20-11:50 TREATMENT OF FIBROIDS
Capsule The incidence of infertility and uterine fibroids increases with women’s increasing age, and so does the association between the two. Non-surgical solutions diversify the doctor’s and patient’s choices
Chairpersons Christian Egarter, Austria
Bart Fauser, The Netherlands
SPRM: Mode of action and latest recommendations
Christian Egarter, Austria
Fibroids and infertility
Nouri Kazem, Austria
Debate: Current management of UF: surgery or Medical treatment for ALL?
Surgical management for ALL: Attilio di Spiezio Sardo, Italy
Medical management for ALL: Josep Estadella Tarriel, Spain
11:50-12:10 Break
12:10-13:40 PGS/PGD
In collaboration with the Hungarian Human Reproduction Society (HHRS)
Capsule While the technique seems to be improving, the question now is can universal PGS improve the results of ART or worsen them?
Chairpersons Attila Vereczkey, Hungary
Elpida Fragouli, UK
David Albertini, USA
Debate: PGS
All embryos should be tested: Simon Fishel, UK
No embryos should be tested: Norbert Gleicher, USA
Discussion
Debate: Detection of mosaicism in trophectoderm biopsies
For: Nathan Treff, USA
Against: Antonio Capalbo, Italy
Discussion
13:40-14:30 lunch break
14:30-16:30 ROLE OF MITOCHONDRIA IN IVF SUCCESS
Capsule Mitochondria, the only (animal) organelles containing DNA outside of the nucleus, are essential for normal fertilization and embryonic development; can they serve as biomarkers for implantation?
Chairperson Rene Frydman, France
David Albertini, USA
PGS on culture media
Wilfried Feichtinger, Austria
Mitochondrial diseases: Technical issues and future therapy
TBA
Mitochondrial DNA (mtDNA) can serve as a biomarker of pre-implantation embryo viability
Elpida Fragouli, UK
Mitochondria as a biomarker for implantation
Nathan Treff, USA
COGI-RBMO countercurrent lecture
Mitochondria are prone to DNA mutations due to the lack of protective histones. Boasting mitochondrial function are used to rejuvenate older age oocytes. Where is the proof?
Boosting mitochondrial function in oocytes increases success: No proof has yet been provided
Simon Fishel, UK
16:30-16:50 coffee break & poster viewing
16:50-18:20 Q & A
Capsule Panelist-audience discussion on acute clinical and lab issues
Chairperson Zion Ben Rafael, Israel
Rene Frydman, France
Panelists Wilfried Feichtinger, Austria
Simon Fishel, UK
Sjoerd Repping, The Netherlands
Basil Tarlatzis, Greece
Nathan Treff, USA
Repeated bad quality embryos? Is it the lab or stimulation?
What to do with RIF?
Time-lapse
POR: Individualization of treatment; how?
Hysteroscopy to all before IVF or by indication?
PCOS: Individualization of treatment; how?
ICSI to all or by indication?
Evidence-based luteal support: What, when and for how long?
Severe Asherman: What is the solution? Surgical? Stem Cells?
Mosaicism: What is the incidence? Why do some PGS labs report mosaicism and others not?
Should mosaic embryos be transferred? What are the risks to the new-born and the practitioners responsible for their transfer?

Friday, December 1, 2017                                                                                                                                             Hall B

08:30-10:00 NATIONAL SESSION OF THE ASSOCIATION OF GYNECOLOGISTS AND OBSTETRICIANS OF SERBIA, MONTENEGRO AND REPUBLIC OF SRPSKA
Chairpersons Stefanović Aleksandar, Serbia
Katarina Jeremić, Serbia
Fertility preservation: New approach
Aleksandar Stefanović, Serbia
Trophoblastic disease: Our experiences
Saša Kadija-Gestational, Serbia
Malignant ovarian tumors and pregnancy
Rakić Snežana, Serbia
Preterm birth: Contemporary approach
Vesna Ećim Zlojutro, Serbia
Hellp syndrome in pregnancy
Miloš Petronijević, Serbia
Cancer in pregnancy: Need for centralization
Katarina Jeremić, Serbia
Prenatal diagnosis of congenital heart defects
Svetlana Vrzić Petronijević, Serbia
Fetal programming in perinatology
Miroslava Gojnić Dugalić, Serbia
Discussion
10:00-10:20 coffee break & poster viewing
10:20-11:50 ARTIFICIAL GAMETES
Capsule  After many years of research, have we gotten any closer to having artificial gametes?
Chairpersons Norbert Gleicher, USA
Artificial gamete: Ready for clinical use?
Björn Heindryckx, Belgium
Artificial ovary
Marie-Madeleine Dolmans, Belgium
Creation of germ cells is the solution for fertility preservation
Sjoerd Repping, The Netherlands
11:50-12:10 Break
12:10-13:40 FERTILITY SPARING OPTIONS IN GYNECOLOGIC ONCOLOGY
Capsule About 10% of all female cancer survivors are younger than 40 years of age. Cancers affecting female genital organs are usually treated by radical surgery, chemotherapy or chemoradiation approaches, which induce permanent damage to reproductive functions. In young women with new diagnoses of cervical, endometrial or ovarian cancers, viable strategies for fertility preservation without compromising oncological outcome exist and should be considered
Chairpersons Heinz Kölbl, Austria
Stephan Polterauer,
Austria
Katarina Jeremić,
Serbia
Fertility-sparing surgery in early-stage cervical cancer
Alexander Reinthaller, Austria
Fertility-sparing management in young endometrial cancer patients
Dominik Denschlag, Germany
Fertility sparing management of ovarian cancer and borderline tumors
Ignacio Zapardiel, Spain
Future trends in prevention of ovarian cancer
Joseph Schenker, Israel
13:40-14:30 lunch break
14:30-16:30 HEREDITARY GYNECOLOGIC CANCER
Capsule Gynecologists and gynecologic oncologists play a major role in identifying and counselling patients at increased risk of inherited cancer syndromes
Chairpersons Ranjit Manchanda, UK
Christian Singer, Austria
Igor Gladchuk, Ukraine
Hereditary breast cancer
Daphne Gschwantler-Kaulich, Austria
Hereditary gynecologic cancers
Christoph Grimm, Austria
Chemoprevention and prophylactic surgery for breast cancer
Georg Pfeiler, Austria
Chemoprevention and prophylactic surgery for ovarian cancer
Ranjit Manchanda, UK
COGI-RBMO countercurrent lecture
Future perspectives in early diagnostic in screening and early diagnostic of epithelial ovarian cancer
Paul Speiser, Austria
16:30-16:50 coffee break & poster viewing
16:50-18:20 FREE COMMUNICATION

Saturday, December 2, 2017                                                                                                                                         Hall B

08:30-10:00 ENDOMETRIOSIS
Capsule Many basic questions regarding the treatment of endometriosis remain unanswered
Chairpersons Mark Hans Emanuel, The Netherlands
Gab Kovacs, Australia
Deep Endometriosis: Back to less aggressive surgery?
Jacques Donnez, Belgium
Debate: Endometrioma before IVF surgery or puncture?
Surgical removal first
Jacques Donnez, Belgium
Conservative therapy including puncture first
Nouri Kazem, Austria
Discussion
Diagnosis of endometriosis: What is new?
Leila Adamyan, Russia
10:00-10:20 coffee break & poster viewing
10:20-11:50 TIME LAPSE
Capsule Time lapse seems like the right tool to close the gaps between the limited examination performed in the IVF laboratory and the dynamic nature of embryonic growth. Continuous monitoring offers information on positive and negative events. Time lapse also offers a list of secondary advantages, but does it allow for automatic embryo selection?
Chairpersons Elpida Fragouli, UK
Norbert Gleicher, USA
Mattheos Fraidakis, Greece
Time lapse to optimize embryo culture: First step towards automation in IVF
Laura Rienzi, Italy
Debate: Time lapse: What have we learned so far? Do universal algorithms work?
No: Rita Vassena, Spain
Yes: Thomas Ebner, Austria
Discussion
Embryo development on day 3-4: What can we learn?
Rita Vassena, Spain
11:50-12:10 Break
12:10-13:40 SURGICAL SOLUTIONS FOR IMPLANTATION FAILURE
Capsule What proof do we have to support the endometrial surgical procedures to enhance implantation?
Chairperson  Nouri Kazem, Austria
Victor Gomel, Canada
Eero Varila, Finland
Endometrial scratching prior to ART is being routinely used in many centers, but it is too controversial to be routine
Mark Hans Emanuel, The Netherlands
Can we make the endometrium more receptive?
Gab Kovacs, Australia
Debate: Does treating thin endometrium and Asherman syndrome require surgery or stem cells?
Proposition: Stem cells for thin endometrium and Asherman syndrome
Xavier Santamaria, Spain
Opposition: You don’t need stem cells; you need good surgeons
Mark Hans Emanuel, The Netherlands
Discussion
13:40-14:30 lunch break
14:30-16:30 ADENOMYOSIS AND FERTILITY
In collaboration with Turkish Society of Reproductive Medicine
Chairpersons Ahmet Zeki Işık, Turkey
Baris Ata, Turkey
  Is vaginal ultrasound all you need to diagnose adenomyosis?
Baris Ata, Turkey
How can surgery improve fertility in adenomyosis? The right procedure for the right patient
Erbil Dogan, Turkey
How to improve assisted reproductive technology outcome for women with adenomyosis
Gurkan Bozdag, Turkey
Pregnancy outcome in women with adenomyosis
Esra Kılıçdağ, Turkey
COGI-RBMO countercurrent lecture:
To be announced shortly
16:30-16:50 coffee break & poster viewing
16:50-18:20 FREE COMMUNICATION

*The scientific program is subject to change.